Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neuland LaboratoriesNSE:NEULANDLAB +2.61%87 3-Year Dividend Growth Rate is 33.90% as of Jun. 2026, which is 25% above its 10-year median of 27.15. GuruFocus rates NSE:NEULANDLAB with a GF Score™ of 87/100 and a GF Value™ of ₹19,388.95 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 350 Drug Manufacturers companies, Neuland Laboratories ranks better than 83.71% on this metric.
The historical rank and industry rank for Neuland Laboratories's 3-Year Dividend Growth Rate or its related term are showing as below:
NSE:NEULANDLAB'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 16 Med: 27.15 Max: 71
Current: 33.9
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Neuland Laboratories was 71.00% per year. The lowest was 16.00% per year. And the median was 27.15% per year.
NSE:NEULANDLAB's 3-Year Dividend Growth Rate is ranked better than 83.71% of 350
companies
in the Drug Manufacturers industry
Industry Median: 7.7
vs NSE:NEULANDLAB: 33.90
During the past 12 months, Neuland Laboratories's average Dividends Per Share Growth Rate was -14.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 33.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 50.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Neuland Laboratories was 0.26. The lowest was 0.03. And the median was 0.05.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Neuland Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 34.000000
2026-07-24
2026-07-24
2026-08-11
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Neuland Laboratories's Dividend Yield (%) for Today is calculated as
Current Share Price is ₹23800.00.
Neuland Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹34.
During the past 13 years, the highest Dividend Yield of Neuland Laboratories was 1.13%. The lowest was 0.05%. And the median was 0.18%.
Good Sign:
Neuland Laboratories Ltd stock Dividend Yield % is close to 2-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuland Laboratories 3-Year Dividend Growth Rate Related Terms>
NSE:NEULANDLAB vs ZTS: 3-Year Dividend Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuland Laboratories 3-Year Dividend Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Neuland Laboratories's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 33.90% mean?
Neuland Laboratories (NSE:NEULANDLAB) has a 3-Year Dividend Growth Rate of 33.90% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Neuland Laboratories and its competitors. This is 25% above median its historical median of 27.15. Over the past decade, Neuland Laboratories' 3-Year Dividend Growth Rate has ranged from 16.00 to 71.00. According to the industry distribution chart, Neuland Laboratories ranks #57 out of 350 companies in the Drug Manufacturers industry, placing it in the top 16.3%.
Is Neuland Laboratories' 3-Year Dividend Growth Rate too high?
Neuland Laboratories' current 3-Year Dividend Growth Rate of 33.90% is 25% above median its 10-year median of 27.15. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 71.00. The Drug Manufacturers industry median 3-Year Dividend Growth Rate is 7.70. Neuland Laboratories' value of 33.90% is 340.3% above this industry median. Based on the distribution chart, Neuland Laboratories ranks #57 out of 350 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Neuland Laboratories has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Neuland Laboratories' 3-Year Dividend Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Neuland Laboratories ranks #57 out of 350 companies for 3-Year Dividend Growth Rate. This places Neuland Laboratories in the top 16% of its industry — outperforming the majority of peers. The industry median 3-Year Dividend Growth Rate is 7.70. Neuland Laboratories' value of 33.90% is 340.3% above this benchmark. Historically, Neuland Laboratories' own 3-Year Dividend Growth Rate has ranged from 16.00 to 71.00 over the past decade. While the company's 10-year median is 27.15 vs. the industry median of 7.70, Neuland Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 3-Year Dividend Growth Rate among Drug Manufacturers companies is 7.70, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuland Laboratories's current 3-Year Dividend Growth Rate of 33.90% is 340.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Neuland Laboratories and its competitors. For the Drug Manufacturers industry, the median 3-Year Dividend Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuland Laboratories's current 3-Year Dividend Growth Rate is 33.90%, which is 25% above median its own 10-year median of 27.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuland Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Neuland Laboratories (NSE:NEULANDLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹19,388.95, compared to a current price of ₹23,800.00 — trading 22.8% above its estimated fair value. The current 3-Year Dividend Growth Rate is 33.90%, which is 25% above median its 10-year median of 27.15 and 340.3% above the Drug Manufacturers industry median of 7.70. Neuland Laboratories' overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Neuland Laboratories (NSE:NEULANDLAB), the current 3-Year Dividend Growth Rate is 33.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuland Laboratories (NSE:NEULANDLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Neuland Laboratories stock appears to be overvalued.
The current stock price of ₹23,800.00 is trading 22.8% above its estimated GF Value™ of ₹19,388.95.
GuruFocus considers Neuland Laboratories to be Modestly Overvalued.
Key valuation signals for NSE:NEULANDLAB:
3-Year Dividend Growth Rate: 33.90% (25% above median its 10-year median of 27.15)
GF Value™: ₹19,388.95 vs. price of ₹23,800.00 (22.8% above fair value)
Industry Position: 340.3% above the Drug Manufacturers median (#57 of 350)
No single metric tells the full story. See the NSE:NEULANDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
87GF Score
Get the complete analysis for NSE:NEULANDLAB
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEULANDLAB has been successfully added to your 
